Tonix Pharmaceuticals Holding Corp.
TNXP
$17.82
$0.633.67%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -8.50% | 27.81% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -8.50% | 27.81% | |||
| Cost of Revenue | -23.92% | -53.82% | |||
| Gross Profit | 10.42% | 209.32% | |||
| SG&A Expenses | 102.18% | 2.73% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 36.38% | -10.65% | |||
| Operating Income | -44.53% | 15.28% | |||
| Income Before Tax | -55.55% | 81.96% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -55.55% | 81.96% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -55.55% | 81.96% | |||
| EBIT | -44.53% | 15.28% | |||
| EBITDA | -42.97% | 13.50% | |||
| EPS Basic | 57.31% | 98.81% | |||
| Normalized Basic EPS | 57.31% | 95.28% | |||
| EPS Diluted | 57.31% | 98.81% | |||
| Normalized Diluted EPS | 57.31% | 95.28% | |||
| Average Basic Shares Outstanding | 264.38% | 1,418.83% | |||
| Average Diluted Shares Outstanding | 264.38% | 1,418.83% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||